SRPT vs VSH · rev $1.13B vs P/E 6033, rev $1.73B
Sarepta Therapeutics Inc (SRPT) versus Vishay Intertechnology Inc (VSH) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Vishay Intertechnology Inc (VSH) is a semiconductors company listed on NYSE.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
Latest reported VSH revenue for 2026-07-04 was $1.73B. Net income was $35.3M. VSH currently screens at market cap $8.21B and trailing P/E 6033.0.
SRPT currently screens at market cap $2.34B. VSH currently screens at market cap $8.21B and trailing P/E 6033.0.
Not investment advice. Open the SRPT and VSH stock pages for the full models.
Not investment advice.